Profile image
Story Views

Last Hour:
Last 24 Hours:

Chemotherapy-induced Nausea and Vomiting Drugs Market Size, Share, Demand and Forecast to 2021

Thursday, March 9, 2017 2:50
% of readers think this story is Fact. Add your two cents.

Market Research Analysts forecast the global CINV drugs market to grow at a CAGR of 5.41% during the period 2017-2021.

According to the report, the high unmet medical need in the market has driven the R&D activities of existing as well as new vendors. Helsinn is one of the leading companies that has a strong pipeline of CINV drugs with two drug candidates in Phase III and Phase I stages. Helsinn has collaborated with Taiho Pharmaceutical for the development and commercialization of netupitant IV in Japan. Heron Therapeutics is developing HTX-019, currently in Phase I stage, for the prevention and treatment of CINV. In addition, new vendors such as Shin Nippon Biomedical Laboratories and Acacia Pharma are aggressively advancing their pipeline to launch new drugs during the forecast period. Shin Nippon Biomedical Laboratories and Acacia are developing granisetron intranasal and APD403, respectively. Both these drugs are in Phase II development stage. These pipeline drugs are expected to gain approval during the forecast period and will likely fuel the market growth.

Download Sample Report @

Covered in this report 

The report covers the present scenario and the growth prospects of the global CINV drugs market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of CINV drugs.

The market is divided into the following segments based on geography: 


Technavio’s report, Global Thoracic Surgery Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors 
Heron Therapeutics

Other prominent vendors 
Acacia Pharma 
Baxter Healthcare 
Dr. Reddy’s Laboratories
Especificos Stendhal 
F. Hoffmann-La Roche 
Kyowa Hakko Kirin
•ee’s Pharmaceutical Holdings 
Midatech Pharma
Ono Pharmaceutical
OPKO Health 
Orchid Chemicals & Pharmaceuticals 
Otsuka Pharmaceutical
Purdue Pharma
Sandoz (a subsidiary of Novartis)
SciClone Pharmaceuticals
Shin Nippon Biomedical Laboratories
Solasia Pharma K.K.
Specialised Therapeutics
Sun Pharma 
Taiho Pharmaceutical 
Teva Pharmaceuticals

Market driver 
Growing preference of chemotherapy drugs in developing countries
For a full, detailed list, view our report 

Market challenge 
Growing popularity of alternate therapies for the treatment of cancer in developed countries
For a full, detailed list, view our report 

Market trend 
Increasing inorganic growth strategies likely to fuel the market growth
For a full, detailed list, view our report 

Key questions answered in this report 
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors? 

Complete Report Details @

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights


PART 05: Disease overview

Understanding the disease


Central pathway

Peripheral pathway

Management of disease

PART 06: Pipeline analysis

PART 07: Market landscape

Global CINV drugs market

Five forces analysis

PART 08: Market segmentation by therapy

Serotonin receptor antagonists

NK1 receptor antoagonists


PART 09: Geographical segmentation

CINV drugs market in Americas

CINV drugs market in EMEA

CINV drugs market in APAC

PART 10: Market drivers

Growing cancer population driving the market growth

Growing preference for chemotherapy drugs in developing countries

Approval of new drugs fuels the market growth

PART 11: Impact of drivers

PART 12: Market challenges



Check Discount On This Report @

For more information, please visit

For more information content with us;

Sam Collins


Market Reports Center 1-646-883-3044 (US)



We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global

Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.